We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

MERIDIAN BIOSCIENCE

Meridian Bioscience manufactures, markets, and distributes diagnostic test kits, purified reagents and biopharmaceuti... read more Featured Products: More products

Download Mobile App





Meridian Showcases Innovative Solutions for Molecular Diagnostics and Immunoassays

By LabMedica International staff writers
Posted on 11 Nov 2024

Meridian Bioscience (Cincinnati, OH, USA) is presenting its innovative solutions in molecular and immunoassay reagents that are designed to simplify assay design, eliminate cold-chain logistics, and improve sustainability. More...

The company is also highlighting its large portfolio of antigens, antibodies, blockers, molecular enzymes, nucleotides, and optimized mixes for qPCR, isothermal amplification, and NGS applications for the IVD industry.

Meridian’s glycerol-free, high-concentration molecular reagents, and services enable the development of ambient-temperature stable assays, eliminating the need for cold chain logistics and ensuring robust and seamless supply chains. This reduces energy consumption in transit and storage as well as minimizes packaging requirements, particularly the use of refrigerant, dry ice, and expanded polystyrene foam. Meridian’s extraction-free, low-temperature molecular solutions streamline workflows by eliminating the need for multiple reagent-based extraction steps and reducing the overall energy consumption required for high-temperature processes. Streamlined workflows with fewer steps result in faster turnaround times and increased throughput, reducing operational energy and resource use. Additionally, Meridian’s animal-free recombinant alternatives for immunoassays (blockers, antibodies, and antigens) can offer greater versatility and reproducibility over animal immunization, ensuring continuity of supply while alleviating ethical concerns.

Meridian is highlighting its recently launched glycerol-free NGS enzymes, further establishing the company as a leader in developing innovative, eco-conscious, and cost-effective components for diagnostic assay developers. Visitors to Meridian’s booth at the show can also learn about the company’s introduction of the market’s first innovative lyophilized Next-Generation Sequencing (NGS) library preparation kit. This revolutionary lyophilized NGS library preparation kit, designed initially for sequencing by synthesis (SBS) protocols, marks a breakthrough in stabilizing the library preparation process at room temperature. The pioneering kit can be transported and stored at ambient temperature and contains ready-to-use lyophilized reactions to simplify the end-repair, A-tailing, ligation, and library amplification steps of most sequencing protocols. By eliminating the requirement for cold-chain shipping and storage, Meridian’s innovative kit not only simplifies logistical and environmental challenges but also significantly reduces carbon emissions and operational costs, thereby streamlining the entire NGS workflow.

Related Links:
Meridian Bioscience


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Chlamydia Pneumoniae Test
Chlamydia Pneumoniae (CP) Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.